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Objective As an adipokine and inflammatory cytokines, chemerin plays an vital role in the 
occurrence and severity of obesity and its related disease such as atherosclerosis (AS), type 2 
diabetes and coronary artery disease, among which the regulation of chemerin on glycolipid 
metabolism is of great important. Chemerin exerts its main biological functions through binding to its 
receptor: G protein-coupled receptor chemokine-like receptor (CMKLR1). Chemerin/CMKLR1 has 
become potential targets for diabetes treatment. For AS, the serum level of chemerin is also related 
to the disorders of glycolipid metabolism as well as the size and fibrous cap maturity of AS plaques. 
Exercise decreased the serum level of chemerin in AS, accompanied with the improvement of glucose 
and lipid metabolism, which indicated the possible relation between decrease of chemerin and 
improvement of glycolipid metabolism. However, it is still unclear whether exercise-induced 
improvements of glycolipid metabolism is associated with the changes of chemerin and CMKLR1 in 
tissue such as livers and gastrocnemius (play key roles in the modulation of glycolipid metabolism) 
and the mechanism by which chemerin/CMKLR1 modulated glycolipid metabolism. Recent studies 
reported that chemerin is a target gene of nuclear transcription factor- peroxisome proliferator 
activated receptor γ (PPARγ). PPARγ links glycolipid metabolism and inflammation through its target 
gene-adipose triglyceride lipase (ATGL) and lipoprotein lipase (LPL), gate-keeping enzymes 
hydrolyzing lipids in intracellular triglyceride and plasma lipoproteins respectively. Our previous 
work has found that aerobic exercise decreased the level of chemerin/CMKLR1 in serum and tissues 
of type 2 diabetes rats by the mediation of PPARγ-ATGL and LPL. So the purposes of this study were 
to clarify if exercise-modulated improvement of glycolipid metabolism of atherosclerosis rats was 
also associated with the changes of chemerin and CMKLR1 in serum and tissues (liver and 
gastrocnemius), similar as in diabetes, and further its mechanisms.  
Methods Twenty-seven male Sprague-Dawley (SD) rats aged 6 weeks were randomly divided into 
control group (Con, n=9) and atherosclerosis (AS, n=18) model rats. AS model rats were established 
by intraperitoneal injection of Vitamin D3 (600,000 IU/kg body weight in the first week, 100,000 
IU/kg body weight in the third week and six week) in combination with 8-week high fat diet feeding. 
For verifying the successful establishment of AS rats, one rat from Con group and two rats from AS 
model group were taken randomly to determine the levels of blood glucose and lipid as well as the 
morphological and pathological alterations of the aorta. Then, 16 successfully established AS rats 
were randomly divided into AS group (n=8) and exercised AS group (EAS, n=8). EAS group rats 
experience 4-week moderate intensity aerobic exercise on treadmill with gradually increasing 
intensity, while the Con and AS rats were kept sedentary life, with all of the rats were fed with 
common diet during the experiments. Before and after 4-week exercise, the blood sample of the 
three group rats were drawn to measure the circulating levels of fasting blood glucose (FBG), 
triglyceride (TC), total cholesterol (TG), LDL and HDL. The serum fasting insulin (FINS) and serum 
chemerin were measured by ELISA. The protein levels of chemerin, CMKLR1, PPARγ, ATGL and LPL 
in livers and gastrocnemius were detected by Western blot. And the full-length aorta of the rats were 
separated to determine AS arteriosclerosis plaques with oil red O staining and histopathological 
examination with HE staining. 
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Results  1) Compared with AS rats, the disorder of glycolipid metabolism (reflected 
by increases in TC, TG, LDL and FINS as well as decrease in HDL in blood although no difference in 
serum level of FBG) were all improved in EAS rats. 2) Compared with AS rats, the atherosclerotic 
plaque in the aoras and the enhanced proliferation and arrangement disorder of smooth muscle cells 
in aorta membrane were all alleviated in EAS rats. 3) Compared with AS rats, the increased chemerin 
in serum and the enhancements of chemerin and CMKLR1 in liver and gastrocnemius at protein 
levels were all significantly decreased in EAS rats. 4) Compared with AS rats, the protein levels of 
PPARγ, ATGL and LPL in the livers and gastrocnemius were all increased in EAS rats. 
Conclusions This study verified that: 1) the exercise-induced improvement of glycolipid metabolism 
in AS rats was likely to be associated with the decreases of chemerin in serum as well as of chemerin 
and CMKLR1 in tissues (liver and gastrocnemius). To our knowledge, it is the first report that 
exercise down-regulated chemerin/CMKLR1 in tissues in AS rats, and the decreases of 
chemerin/CMKLR1 might be related to the improvement of glycolipid metabolism in AS rats. 2) the 
exercise-induced decreases of chemerin/CMKLR1 in AS rats might be mediated by PPARγ and its 
target genes- ATGL and LPL, which need further investigations. 
 
